It Takes Three [Components] to Make a Thing Go Riiiiiight – OPDP Challenges Two-Part Ad
FDA Law Blog
JANUARY 26, 2022
This content is likely one of the reasons for FDA’s withdrawal of the Draft Guidance in 2015 – the same year that FDA suffered one of the most significant blows regarding First Amendment protections for pharmaceutical manufacturer speech. Where FDA does not have jurisdiction, the agency may nevertheless take appropriate action (e.g.,
40 
Let's personalize your content